Evidence map›Paper›PMID 38594816›Full record

ArticleJournal of proteome research2024

Analysis of Vascular Smooth Muscle Cells from Thoracic Aortic Aneurysms Reveals DNA Damage and Cell Cycle Arrest as Hallmarks in Bicuspid Aortic Valve Patients.

Ariadna Martin-Blazquez, Marta Martin-Lorenzo, Aranzazu Santiago-Hernandez, Angeles Heredero, Alicia Donado, Juan A Lopez, Miriam Anfaiha-Sanchez, Rocio Ruiz-Jimenez, Vanesa Esteban, Jesus Vazquez and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of proteome research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Ariadna Martin-BlazquezImmunology Department, IIS-Fundación Jiménez Díaz, Fundación Jiménez Díaz Hospital-UAM, 28040 Madrid, Spain.
Marta Martin-LorenzoImmunology Department, IIS-Fundación Jiménez Díaz, Fundación Jiménez Díaz Hospital-UAM, 28040 Madrid, Spain.
Aranzazu Santiago-HernandezImmunology Department, IIS-Fundación Jiménez Díaz, Fundación Jiménez Díaz Hospital-UAM, 28040 Madrid, Spain.
Angeles HerederoCardiac Surgery Service, Fundación Jiménez Díaz Hospital-UAM, 28040 Madrid, Spain.
Alicia DonadoCardiac Surgery Service, Fundación Jiménez Díaz Hospital-UAM, 28040 Madrid, Spain.
Juan A LopezLaboratory of Cardiovascular Proteomics, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain.
Miriam Anfaiha-SanchezImmunology Department, IIS-Fundación Jiménez Díaz, Fundación Jiménez Díaz Hospital-UAM, 28040 Madrid, Spain.
Rocio Ruiz-JimenezImmunology Department, IIS-Fundación Jiménez Díaz, Fundación Jiménez Díaz Hospital-UAM, 28040 Madrid, Spain.
Vanesa EstebanDepartment of Allergy and Immunology, IIS-Fundación Jiménez Díaz, Fundación Jiménez Díaz Hospital-UAM, 28040 Madrid, Spain.
Jesus VazquezLaboratory of Cardiovascular Proteomics, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain.
Gonzalo Aldamiz-EchevarriaCardiac Surgery Service, Fundación Jiménez Díaz Hospital-UAM, 28040 Madrid, Spain.
Gloria Alvarez-LlamasImmunology Department, IIS-Fundación Jiménez Díaz, Fundación Jiménez Díaz Hospital-UAM, 28040 Madrid, Spain.ORCID 0000-0002-3313-721X
Hospital Universitario Fundación Jiménez Díaz · ESSpanish National Centre for Cardiovascular Research · ESUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thoracic aortic aneurysm (TAA) is mainly sporadic and with higher incidence in the presence of a bicuspid aortic valve (BAV) for unknown reasons. The lack of drug therapy to delay TAA progression lies in the limited knowledge of pathophysiology. We aimed to identify the molecular hallmarks that differentiate the aortic dilatation associated with BAV and tricuspid aortic valve (TAV). Aortic vascular smooth muscle cells (VSMCs) isolated from sporadic TAA patients with BAV or TAV were analyzed by mass spectrometry. DNA oxidative damage assay and cell cycle profiling were performed in three independent cohorts supporting proteomics data. The alteration of secreted proteins was confirmed in plasma. Stress phenotype, oxidative stress, and enhanced DNA damage response (increased S-phase arrest and apoptosis) were found in BAV-TAA patients. The increased levels of plasma C1QTNF5, LAMA2, THSB3, and FAP confirm the enhanced stress in BAV-TAA. Plasma FAP and BGN point to an increased inflammatory condition in TAV. The arterial wall of BAV patients shows a limited capacity to counteract drivers of sporadic TAA. The molecular pathways identified support the need of differential molecular diagnosis and therapeutic approaches for BAV and TAV patients, showing specific markers in plasma which may serve to monitor therapy efficacy.

Indexed as

Aortic Aneurysm, ThoracicAortic ValveBicuspid Aortic Valve DiseaseCell Cycle CheckpointsDNA DamageMuscle, Smooth, VascularMyocytes, Smooth MuscleAgedApoptosisFemaleHeart Valve DiseasesHumansMaleMiddle AgedOxidative StressProteomicsaortic aneurysmbicuspid aortic valvecardiovascular diseaseDNA damageoxidative stressproteomicsvascular smooth muscle cells

Identifiers

PMID38594816
PMCPMC11301675
OpenAlexW4394686096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.